4.6 Review

Achieving higher efficacy without compromising safety with factor XI inhibitors versus low molecular weight heparin for the prevention of venous thromboembolism in major orthopedic surgery-Systematic review and meta-analysis

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Medicine, General & Internal

Milvexian for the Prevention of Venous Thromboembolism

Jeffrey Weitz et al.

Summary: The study results showed that in knee arthroplasty patients receiving different doses of milvexian treatment, the incidence of venous thromboembolism with twice-daily dosing was significantly lower than the prespecified benchmark of 30%, with a lower risk of bleeding compared to enoxaparin.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Review Hematology

Factor XI as a Target for New Anticoagulants

James C. Fredenburgh et al.

Summary: The article discusses the rationale for developing factor XI inhibitors, identifies the most advanced stage agents, describes the results of completed clinical trials and ongoing trials, highlighting opportunities and challenges for this new generation of anticoagulants.

HAMOSTASEOLOGIE (2021)

Review Cardiac & Cardiovascular Systems

Factor XI Inhibition to Uncouple Thrombosis From Hemostasis JACC Review Topic of the Week

Charles Hsu et al.

Summary: Hemostasis and thrombosis are closely linked, with factor XI inhibitors potentially providing a safer alternative to current anticoagulants. Clinical studies are ongoing to determine the efficacy of factor XI inhibitors in attenuating thrombosis without disrupting hemostasis.

JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2021)

Article Medicine, General & Internal

Abelacimab for Prevention of Venous Thromboembolism

Peter Verhamme et al.

Summary: Factor XI plays a significant role in the development of postoperative venous thromboembolism. Inhibition of Factor XI with a single intravenous dose of abelacimab after total knee arthroplasty was effective in preventing venous thromboembolism and had a low risk of bleeding.

NEW ENGLAND JOURNAL OF MEDICINE (2021)

Article Medicine, General & Internal

Effect of Osocimab in Preventing Venous Thromboembolism Among Patients Undergoing Knee Arthroplasty The FOXTROT Randomized Clinical Trial

Jeffrey I. Weitz et al.

JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2020)

Article Hematology

Intrinsic Pathway of Coagulation and Thrombosis: Insights From Animal Models

Steven P. Grover et al.

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2019)

Article Hematology

New developments in anticoagulants: Past, present and future

Jeffrey I. Weitz et al.

THROMBOSIS AND HAEMOSTASIS (2017)

Article Medicine, General & Internal

Factor XI Antisense Oligonucleotide for Prevention of Venous Thrombosis

Harry R. Bueller et al.

NEW ENGLAND JOURNAL OF MEDICINE (2015)

Article Medicine, General & Internal

Apixaban or Enoxaparin for Thromboprophylaxis after Knee Replacement

Michael Rud Lassen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2009)

Article Medicine, General & Internal

Rivaroxaban versus enoxaparin for thromboprophylaxis after total knee arthroplasty

Michael R. Lassen et al.

NEW ENGLAND JOURNAL OF MEDICINE (2008)

Review Hematology

Role of tissue factor in hemostasis, thrombosis, and vascular development

N Mackman

ARTERIOSCLEROSIS THROMBOSIS AND VASCULAR BIOLOGY (2004)

Article Medicine, General & Internal

Fondaparinux compared with enoxaparin for the prevention of venous thromboembolism after elective major knee surgery.

KA Bauer et al.

NEW ENGLAND JOURNAL OF MEDICINE (2001)